174 related articles for article (PubMed ID: 29453286)
1. Chaperone substrate provides missing link for cancer drug discovery.
Byrd KM; Blagg BSJ
J Biol Chem; 2018 Feb; 293(7):2381-2382. PubMed ID: 29453286
[TBL] [Abstract][Full Text] [Related]
2. X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition.
Cesa LC; Shao H; Srinivasan SR; Tse E; Jain C; Zuiderweg ERP; Southworth DR; Mapp AK; Gestwicki JE
J Biol Chem; 2018 Feb; 293(7):2370-2380. PubMed ID: 29255093
[TBL] [Abstract][Full Text] [Related]
3. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
Wang Y; McAlpine SR
Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223
[TBL] [Abstract][Full Text] [Related]
4. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
Håvik B; Bramham CR
Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling.
Genest O; Wickner S; Doyle SM
J Biol Chem; 2019 Feb; 294(6):2109-2120. PubMed ID: 30401745
[TBL] [Abstract][Full Text] [Related]
6. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
7. Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.
Shevtsov M; Multhoff G; Mikhaylova E; Shibata A; Guzhova I; Margulis B
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652993
[TBL] [Abstract][Full Text] [Related]
8. Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective.
Workman P
Adv Exp Med Biol; 2020; 1243():163-179. PubMed ID: 32297218
[TBL] [Abstract][Full Text] [Related]
9. Death by chaperone: HSP90, HSP70 or both?
Powers MV; Clarke PA; Workman P
Cell Cycle; 2009 Feb; 8(4):518-26. PubMed ID: 19197160
[TBL] [Abstract][Full Text] [Related]
10. Alternative approaches to Hsp90 modulation for the treatment of cancer.
Hall JA; Forsberg LK; Blagg BS
Future Med Chem; 2014 Sep; 6(14):1587-605. PubMed ID: 25367392
[TBL] [Abstract][Full Text] [Related]
11. Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy.
Cui XB; Yu ZY; Wang W; Zheng YQ; Liu W; Li LX
Integr Cancer Ther; 2012 Mar; 11(1):61-7. PubMed ID: 21498475
[TBL] [Abstract][Full Text] [Related]
12. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?
Powers MV; Jones K; Barillari C; Westwood I; van Montfort RL; Workman P
Cell Cycle; 2010 Apr; 9(8):1542-50. PubMed ID: 20372081
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents.
Nitzsche B; Höpfner M; Biersack B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835501
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors and chemical probes for molecular chaperone networks.
Gestwicki JE; Shao H
J Biol Chem; 2019 Feb; 294(6):2151-2161. PubMed ID: 30213856
[TBL] [Abstract][Full Text] [Related]
15. Hsp110 chaperones control client fate determination in the hsp70-Hsp90 chaperone system.
Mandal AK; Gibney PA; Nillegoda NB; Theodoraki MA; Caplan AJ; Morano KA
Mol Biol Cell; 2010 May; 21(9):1439-48. PubMed ID: 20237159
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations.
Yaglom JA; Wang Y; Li A; Li Z; Monti S; Alexandrov I; Lu X; Sherman MY
Sci Rep; 2018 Feb; 8(1):3010. PubMed ID: 29445088
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HSP70: a challenging anti-cancer strategy.
Goloudina AR; Demidov ON; Garrido C
Cancer Lett; 2012 Dec; 325(2):117-24. PubMed ID: 22750096
[TBL] [Abstract][Full Text] [Related]
18. Heat shock proteins at the crossroads between cancer and Alzheimer's disease.
Wang H; Tan MS; Lu RC; Yu JT; Tan L
Biomed Res Int; 2014; 2014():239164. PubMed ID: 25147790
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 90: the cancer chaperone.
Neckers L
J Biosci; 2007 Apr; 32(3):517-30. PubMed ID: 17536171
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening based identification of miltefosine and octenidine as inhibitors of heat shock protein 90.
Li L; Yang M; Li C; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2223-2232. PubMed ID: 34406420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
